Svb Wealth LLC Bio N Tech Se Transaction History

Svb Wealth LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$98.5 - $125.08 $788 - $1,000	8 Added 0.42%	1,917 $208,000
Q2 2023 Jul 24, 2023	BUY	$102.58 - $129.66 $1,846 - $2,333	18 Added 0.95%	1,909 $206,000
Q1 2023 May 12, 2023	SELL	$122.57 - $153.67 $28,436 - $35,651	-232 Reduced 10.93%	1,891 $235,000
Q4 2022 Feb 10, 2023	SELL	$118.43 - $186.05 $2,960 - $4,651	-25 Reduced 1.16%	2,123 $318,000
Q3 2022 Nov 09, 2022	BUY	$127.65 - $183.11 $33,189 - $47,608	260 Added 13.77%	2,148 $289,000
Q2 2022 Aug 16, 2022	BUY	$123.25 - $186.24 $123 - $186	1 Added 0.05%	1,888 $281,000
Q1 2022 May 13, 2022	SELL	$126.25 - $231.85 $6,186 - $11,360	-49 Reduced 2.53%	1,887 $322,000
Q4 2021 Feb 15, 2022	BUY	$216.64 - $362.52 $27,080 - $45,315	125 Added 6.9%	1,936 $499,000
Q3 2021 Nov 09, 2021	BUY	$205.93 - $447.23 $1,029 - $2,236	5 Added 0.28%	1,811 $494,000
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $204,655 - $436,130	1,806 New	1,806 $404,000
Q1 2021 May 11, 2021	SELL	$85.73 - $119.5 $257,190 - $358,500	-3,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$72.71 - $129.54 $218,129 - $388,620	3,000 New	3,000 $245,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Svb Wealth LLC with notifications on news.